Displaying 1 result from an estimated 1 matches for "opharma".
Did you mean:
pharma
2010 Aug 20
0
Wanted :BioInformatics Scientist - Heavy "R" focus
...39;s lead product, Tivozanib, is an oral, triple VEGF receptor
inhibitor with potential for a best-in-class profile. Tivozanib is
currently being investigated in a global, randomized Phase 3 clinical
trial called TIVO-1
<http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.ave
opharma.com%2Ffor_patients%2F&esheet=6299494&lan=en_US&anchor=TIVO-1&ind
ex=1&md5=445a20da41b339efa84d364a08f882ec> comparing Tivozanib to
Sorafenib in advanced kidney cancer, as well as additional clinical
studies in other solid tumor types. AVEO's proprietary, integrated
cance...